These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1101901)

  • 1. A new isoniazid preparation designed for moderately fast and "fast" metabolizers of the drug.
    Eidus L; Hodgkin MM
    Arzneimittelforschung; 1975 Jul; 25(7):1077-80. PubMed ID: 1101901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The type of isoniazid acetylation in tuberculosis patients treated at National Tuberculosis and Lung Diseases Research Institute.
    Augustynowicz-Kopeć E; Zwolska Z
    Acta Pol Pharm; 2002; 59(6):443-7. PubMed ID: 12669768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
    Augustynowicz-Kopeć E; Zwolska Z
    Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
    Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of polymorphic N-acetyltransferase phenotype on the inhibition and induction of acetaminophen bioactivation with long-term isoniazid.
    Chien JY; Peter RM; Nolan CM; Wartell C; Slattery JT; Nelson SD; Carithers RL; Thummel KE
    Clin Pharmacol Ther; 1997 Jan; 61(1):24-34. PubMed ID: 9024171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative blood levels and metabolism of INH and an INH-matrix preparation in fast and slow inactivators.
    Jeanes CW; Schaefer O; Eidus L
    Can Med Assoc J; 1973 Sep; 109(6):483-7. PubMed ID: 4742916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bioavailability of isoniazid in healthy volunteers--fast and slow INH acetylators].
    Augustynowicz-Kopeć E; Zwolska Z; Niemirowska-Mikulska H
    Pneumonol Alergol Pol; 2002; 70(3-4):167-79. PubMed ID: 12271964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release isoniazid tablets. I--Formulation and in vitro evaluation.
    Bulut-Oner F; Capan Y; Kas S; Oner L; Hincal AA
    Farmaco; 1989; 44(7-8):739-52. PubMed ID: 2590371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation].
    Miscoria G; Leneveu A; Walle C; Roux A
    Ann Biol Clin (Paris); 1988; 46(9):734-40. PubMed ID: 3223632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
    Bouayad Z; Chevalier B; Maurin R; Bartal M
    Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of food on the bioavailability of isoniazid in health volunteers].
    Zwolska Z; Niemirowska-Mikulska H; Augustynowicz-Kopeć E
    Pneumonol Alergol Pol; 1998; 66(7-8):412-21. PubMed ID: 10354690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of isoniazid acetylation phenotypes in North Indians.
    Gupta RC; Nair CR; Jindal SK; Malik SK
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):259-64. PubMed ID: 6746149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid isoniazid concentrations in children with tuberculous meningitis: the influence of dosage and acetylation status.
    Donald PR; Gent WL; Seifart HI; Lamprecht JH; Parkin DP
    Pediatrics; 1992 Feb; 89(2):247-50. PubMed ID: 1734391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of children as slow or rapid acetylators based on concentrations of isoniazid in saliva following oral administration of body-weight and surface-area-related dosages of the drug.
    Sarma GR; Kailasam S; Datta M; Loganathan GK; Rahman F; Narayana AS
    Indian Pediatr; 1990 Feb; 27(2):134-42. PubMed ID: 2361757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isoniazid acetylation in a group of Tunisian patients. Report of 620 patients].
    Mehiri BR; Zouaoui A; Chérif J; Ourari B; Daghfous R; Oueslati MH; Louzir B; Daghfous J; Chelbi B; Béji M
    Tunis Med; 2005 Jul; 83(7):385-9. PubMed ID: 16220693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ; Cynamon MH
    J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
    Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
    Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylation pharmacogenetics: experimental models for human toxicity.
    Weber WW
    Fed Proc; 1984 May; 43(8):2332-7. PubMed ID: 6714442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of coadministration of procainamide and isoniazid on each other's acetylation pathway.
    Schneck DW; Sprouse JS; Shiroff RA; Vary JE; DeWitt FO; Hayes AH
    Pharmacology; 1979; 18(1):34-41. PubMed ID: 419159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.